Based in Le Mont-sur-Lausanne, RegenBCT® is one of the leading manufacturers of medical products for the processing of platelet-rich plasma (A-PRP).
Based in Le Mont-sur-Lausanne, RegenBCT® is one of the leading manufacturers of medical products for the processing of platelet-rich plasma (A-PRP).
99.7% free of erythrocytes
More than 2 million patients
170+ published studies
Regen BCT contains sodium citrate (anticoagulant) and a patented separating gel to separate the plasma and the thrombocytes from the erythrocytes and granulocytes. This process occurs in a closed system without any contamination. RegenBCT® tubes are made of medical-grade glass and come with a vacuum to ensure easy and automatic blood withdrawal.
Platelet concentrates processed with RegenLab technology offer an autologous reservoir of growth factors.
Platelets are crucial to the mechanisms of tissue repair. They deliver essential growth factors, such as FGF, PDGF, TGF-β, EGF, VEGF and IGF, which participate in the migration, differentiation and proliferation of stem cells. Thrombocytes also stimulate fibroblasts and endothelial cells, thus inducing the fortification of a new extracellular matrix and neovascularisation. The thrombocytes are concentrated from the patient's own blood.
Blood plasma contains many factors which are crucial to the cells' survival, such as nutrients like vitamins, hormones, electrolytes, growth factors (IGF and HGF) and proteins. Among the plasma proteins are the molecules which are decisive for the clotting process and the formation of the fibrin polymer, the latter of which serves as a structure for cell migration and the formation of new tissue.
